Couverture de The 'Dispatched' Podcast

The 'Dispatched' Podcast

The 'Dispatched' Podcast

De : Daily Dispatch
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.

© 2025 The 'Dispatched' Podcast Politique et gouvernement
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • The 'Dispatched' Week in Review Podcast - 12 December

      The 'Dispatched' Week in Review Podcast - 12 December
      Dec 12 2025

      Not for the first time, some Australian politicians are in trouble over their use of very generous travel entitlements. We discuss why it matters for patients and why the claim that they are acting within the rules does not stack up.
      Afficher plus Afficher moins
      45 min
    • The 'Dispatched' Week in Review'- 5 December

      The 'Dispatched' Week in Review'- 5 December
      Dec 5 2025

      A turbulent round of Senate Estimates, highlighted by a heartbreaking exchange about a mother with two children battling Crohn’s disease. Officials suggested that the family seek compassionate access from companies or seek treatment at a public hospital. We also canvass ‘MFN’ pricing risks, FOI controversies, ministerial travel blowouts and looming budget pressures that do not operate according to what might be a common understanding.
      Afficher plus Afficher moins
      53 min
    • The 'Dispatched' Podcast - 30 November

      The 'Dispatched' Podcast - 30 November
      Nov 30 2025

      In this week’s Dispatched Podcast, we unpack the AI Health Summit and agree it revealed a gap between institutional caution and the real-world pace of its adoption. The practical reality of the proposed ban on genetic testing for life insurance, the self-limiting nature of Australia’s health reform processes, the status quo bias, and the absence of any genuine patient-centred purpose in current settings. We also discuss productivity, a critical roundtable, access inequities and the opportunity to broaden the discussion by not accepting the ‘framing’ of choices.
      Afficher plus Afficher moins
      1 h et 3 min
    Aucun commentaire pour le moment